216 related articles for article (PubMed ID: 25236854)
1. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
Chung P; Daugaard G; Tyldesley S; Atenafu EG; Panzarella T; Kollmannsberger C; Warde P
Cancer Med; 2015 Jan; 4(1):155-60. PubMed ID: 25236854
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
5. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
8. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
Aparicio J; Maroto P; García Del Muro X; Sánchez-Muñoz A; Gumà J; Margelí M; Sáenz A; Sagastibelza N; Castellano D; Arranz JA; Hervás D; Bastús R; Fernández-Aramburo A; Sastre J; Terrasa J; López-Brea M; Dorca J; Almenar D; Carles J; Hernández A; Germà JR
Ann Oncol; 2014 Nov; 25(11):2173-2178. PubMed ID: 25210015
[TBL] [Abstract][Full Text] [Related]
10. Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
Kamba T; Kamoto T; Okubo K; Teramukai S; Kakehi Y; Matsuda T; Ogawa O
Int J Urol; 2010 Dec; 17(12):980-7. PubMed ID: 20955354
[TBL] [Abstract][Full Text] [Related]
11. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
[TBL] [Abstract][Full Text] [Related]
12. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
[TBL] [Abstract][Full Text] [Related]
13. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review.
Zengerling F; Kunath F; Jensen K; Ruf C; Schmidt S; Spek A
Urol Oncol; 2018 Oct; 36(10):448-458. PubMed ID: 28712790
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
[TBL] [Abstract][Full Text] [Related]
16. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
[TBL] [Abstract][Full Text] [Related]
17. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.
Aparicio J
Clin Transl Oncol; 2018 Oct; 20(10):1358-1359. PubMed ID: 29744734
[No Abstract] [Full Text] [Related]
19. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.
Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
